Laser opens door to better burn scar treatment
NCT ID NCT07660120
First seen Jun 27, 2026 · Last updated Jul 01, 2026 · Updated 1 time
Summary
This study tests whether adding a medication called 5-fluorouracil to a standard steroid treatment helps improve thick, raised burn scars more than the steroid alone. Both treatments are delivered through tiny holes made by a CO2 laser, which helps the medications reach deeper into the scar. Each participant's scar is split in half, with one side receiving both drugs and the other side only the steroid, allowing a direct comparison. The goal is to see if the combination reduces scar thickness and stiffness better.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
triamcinolone acetonide and 5-fluorouracil
What this could lead to
If adding 5-FU works better, it could offer a less painful, more effective way to treat thick burn scars.
What could go wrong
This is a small, early-stage study. The added medication may not improve results and could cause side effects like skin irritation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BURN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••